Cocrystal Pharma, Inc. (NASDAQ:COCP – Free Report)’s share price was down 2% during mid-day trading on Wednesday . The stock traded as low as $2.41 and last traded at $2.42. Approximately 10,238 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 61,339 shares. The stock had previously closed […]
StockNews.com lowered shares of Royalty Pharma (NASDAQ:RPRX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning. RPRX has been the subject of a number of other research reports. Tigress Financial boosted their price objective on Royalty Pharma from $57.00 to $60.00 and gave […]
Royalty Pharma (NASDAQ:RPRX – Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday. RPRX has been the subject of several other reports. Morgan Stanley boosted their target price on Royalty Pharma from $48.00 to $50.00 and gave the company […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) CEO Ron Bentsur acquired 750 shares of the stock in a transaction dated Monday, June 26th. The stock was acquired at an average cost of $16.50 per share, with a total value of $12,375.00. Following the purchase, the chief executive officer now owns 3,230,779 shares of the company’s […]
Destiny Pharma plc (LON:DEST – Free Report) reached a new 52-week low on Thursday . The company traded as low as GBX 27 ($0.34) and last traded at GBX 27.60 ($0.35), with a volume of 280033 shares. The stock had previously closed at GBX 29.40 ($0.37). Analysts Set New Price Targets Separately, Shore Capital reaffirmed […]